Trial Information
PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?
Inclusion Criteria:
- 18 years or older
- patients with high-grade glioma who will undergo adjuvant radiochemotherapy after
surgery
Exclusion Criteria:
- low global performance state
- pregnancy
- lactation period
- presence of pacemaker, vascular clips in the brain ,epidural electrodes, implanted
hearing device, set of false theeth attached by means of magnetes, wig attached by
means of metal clips
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
time to local recurrence after neurosurgery and adjuvant radiochemotherapy
Outcome Time Frame:
18 months
Safety Issue:
Yes
Principal Investigator
Ingeborg Goethals, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Hospital, Ghent
Authority:
Belgium: Federal Agency for Medicinal Products and Health Products
Study ID:
2008/085
NCT ID:
NCT00628940
Start Date:
January 2010
Completion Date:
October 2012
Related Keywords:
- High-grade Glioma of the Brain
- Glioma
- Recurrence